RealFeedApp beta
- Rhode Island launches Brain Health Collaboratory
The Rhode Island Brain Health Collaboratory has launched, uniting Cognito Therapeutics with local health systems to conduct clinical research and deploy neuromodulation protocols via the Spectris platform. The company states that Spectris AD received FDA Breakthrough Device designation and that Cognito has raised over $220 million in private financing.
- Field
- industry news
- What they did
- Cognito Therapeutics and the Rhode Island Life Science Hub launched a brain health center to unite local health systems for evaluating and deploying the Spectris platform, which optimizes neuromodulation protocols.
- Why it matters
- This accelerates clinical trials because Spectris AD already holds an FDA Breakthrough Device designation, and the company has raised over $220 million in private financing.
#cognito therapeutics#spectris#neuromodulation#fda breakthrough device#rhode island
